Günter Wolf

5.4k total citations · 1 hit paper
70 papers, 4.5k citations indexed

About

Günter Wolf is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Günter Wolf has authored 70 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Cardiology and Cardiovascular Medicine and 19 papers in Oncology. Recurrent topics in Günter Wolf's work include Renin-Angiotensin System Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Günter Wolf is often cited by papers focused on Renin-Angiotensin System Studies (23 papers), Cancer-related Molecular Pathways (10 papers) and Chronic Kidney Disease and Diabetes (9 papers). Günter Wolf collaborates with scholars based in Germany, United States and France. Günter Wolf's co-authors include Rolf A.K. Stahl, Fuad N. Ziyadeh, Sheldon Chen, Dong Cheol Han, Gunther Zahner, Friedrich Thaiss, Stuart J. Shankland, Ulrich Wenzel, Regine Schroeder and Udo Helmchen and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Günter Wolf

69 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin and renal disease

2002 730 citations Günter Wolf, Sheldon Chen et al. American Journal of Kidney Diseases profile →

Peers

Countries citing papers authored by Günter Wolf

Since Specialization

Citations

This map shows the geographic impact of Günter Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günter Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günter Wolf more than expected).

Fields of papers citing papers by Günter Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günter Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günter Wolf. The network helps show where Günter Wolf may publish in the future.

Co-authorship network of co-authors of Günter Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Günter Wolf. A scholar is included among the top collaborators of Günter Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günter Wolf. Günter Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment of osteoporosis after liver transplantation with ibandronate 2010 ·Transplant International ·Daniel Kaemmerer, Gabriele Lehmann, Günter Wolf, Utz Settmacher, Merten Hommann	18
2	Bone histomorphometry after treatment with teriparatide (PTH 1-34) in a patient with adynamic bone disease subsequent to parathyroidectomy 2008 ·Clinical Kidney Journal ·G. Lehmann, U. Ott, (unknown), Günter Wolf	6
3	Compartment-Specific Expression and Function of the Chemokine IP-10/CXCL10 in a Model of Renal Endothelial Microvascular Injury 2005 ·Journal of the American Society of Nephrology ·Ulf Panzer, Oliver M. Steinmetz, (unknown), Tobias Meyer, Susanne Fehr, André Schneider, Gunther Zahner, Günter Wolf, Udo Helmchen, Patrick Schaerli, Rolf A.K. Stahl, Friedrich Thaiss	78
4	Oxidized LDL Induces Proliferation and Hypertrophy in Human Umbilical Vein Endothelial Cells via Regulation of p27Kip1 Expression 2004 ·Journal of the American Society of Nephrology ·Stefan Seibold, (unknown), Alexandra N. Heinloth, Günter Wolf, Martin Wagner, Jan Galle	40
5	A 63-year-old man with acute abdominal pain and laboratory signs of rapid progressive renal disease 2004 ·Nephrology Dialysis Transplantation ·Günter Wolf, (unknown), Susan Petri, Udo Helmchen, Rolf A.K. Stahl	0
6	CD2-associated protein and glomerular disease 2003 ·The Lancet ·Günter Wolf, Rolf A.K. Stahl	63
7	Angiotensin II–induced hypertrophy of proximal tubular cells requires p27Kip1 2003 ·Kidney International ·Günter Wolf, (unknown), Regine Schroeder, (unknown), Stuart J. Shankland, Rolf A.K. Stahl	27
8	After all those fat years: renal consequences of obesity 2003 ·Nephrology Dialysis Transplantation ·Günter Wolf	43
9	Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis11See Editorial by de Zeeuw, p. 1176. 2002 ·Kidney International ·Ulrich Wenzel, Friedrich Thaiss, U. Helmchen, Rolf A.K. Stahl, Günter Wolf	18
10	Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II 2002 ·Kidney International ·Jens Gerth, Jörg Kriegsmann, (unknown), Rolf A.K. Stahl, Thoralf Wendt, Manfred Sommer, Günter Stein, Günter Wolf	20
11	Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors11See Editorial by Luft, p. 2272. 2002 ·Kidney International ·Günter Wolf, Ulrich Wenzel, Kevin D. Burns, Raymond C. Harris, Rolf A.K. Stahl, Friedrich Thaiss	185
12	Leptin and renal disease breakdown → 2002 ·American Journal of Kidney Diseases ·Günter Wolf, Sheldon Chen, Dong Cheol Han, Fuad N. Ziyadeh	730
13	Cyclooxygenase-2 Overexpression Inhibits Platelet-derived Growth Factor-induced Mesangial Cell Proliferation through Induction of the Tumor Suppressor Gene p53 and the Cyclin-dependent Kinase Inhibitors p21waf-1/cip-1 and p27kip-1 2002 ·Journal of Biological Chemistry ·Gunther Zahner, Günter Wolf, (unknown), (unknown), Ulf Panzer, Stuart J. Shankland, Rolf A.K. Stahl	49
14	High Glucose-Induced Hypertrophy of Mesangial Cells Requires p27Kip1, an Inhibitor of Cyclin-Dependent Kinases 2001 ·American Journal Of Pathology ·Günter Wolf, Regine Schroeder, Gunther Zahner, Rolf A.K. Stahl, Stuart J. Shankland	102
15	Angiotensin II as a Renal Growth Factor 2001 ·Contributions to nephrology ·Günter Wolf	12
16	Regulatory peptides and their antagonists in nephropathies 2000 ·Current Opinion in Nephrology & Hypertension ·Günter Wolf, Ulf Panzer, Rolf A.K. Stahl	5
17	Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-β 1999 ·Kidney International ·André Schneider, Ulf Panzer, Gunther Zahner, Ulrich Wenzel, Günter Wolf, Friedrich Thaiss, Udo Helmchen, Rolf A.K. Stahl	90
18	Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. 1997 ·Journal of Clinical Investigation ·Günter Wolf, Fuad N. Ziyadeh, Friedrich Thaiss, (unknown), Rachel Caron, Ulrich Wenzel, Gunther Zahner, Udo Helmchen, Rolf A.K. Stahl	213
19	CYCLOSPORINE STIMULATES EXPRESSION OF TRANSFORMING GROWTH FACTOR-β IN RENAL CELLS POSSIBLE MECHANISM OF CYCLOSPORINES ANTIPROLIFERATIVE EFFECTS 1995 ·Transplantation ·Günter Wolf, Friedrich Thaiss, Rolf A.K. Stahl	121
20	Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta. 1993 ·Journal of Clinical Investigation ·Günter Wolf, (unknown), Rolf A.K. Stahl, Fuad N. Ziyadeh	324

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact